| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/26/2004 | WO2004042026A3 NUCLEIC ACID AND ALLERGENIC POLYPEPTIDES ENCODED THEREBY IN CASHEW NUTS (Anacardium occidentale) |
| 08/26/2004 | WO2004039834A3 Recombinant protein variants |
| 08/26/2004 | WO2004035787A3 Transplantable cell with immune modulator |
| 08/26/2004 | WO2004035755A3 Transporters and ion channels |
| 08/26/2004 | WO2004035735A3 A structured peptide scaffold for displaying turn libraries on phage |
| 08/26/2004 | WO2004035621A3 Rad51-brc repeat crystals |
| 08/26/2004 | WO2004033689A3 Polypeptides involved in spiramycin biosynthesis, nucleotide sequences encoding said polypeptides and uses thereof |
| 08/26/2004 | WO2004031356A3 Recombinant intracellular pathogen immunogenic compositions and methods for use |
| 08/26/2004 | WO2004031208A3 Promoter sequences for corticotropin releasing factor binding protein and use thereof |
| 08/26/2004 | WO2004024092A3 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 08/26/2004 | WO2004020607A3 SPAN-Xb GENE AND PROTEIN FOR THE DIAGNOSIS AND TREATMENT OF CANCER |
| 08/26/2004 | WO2004020594A3 Solanum bulbocastanum late blight resistance gene and use thereof |
| 08/26/2004 | WO2004018706A3 A genomic approach to identification of novel broad-spectrum antimicrobial peptides from bony fish |
| 08/26/2004 | WO2004018684A3 T-cell epitopes in staphylococcal enterotoxin b |
| 08/26/2004 | WO2004015066A3 Sperm-specific cation channel, catsper-4, and uses therefor |
| 08/26/2004 | WO2004011615A3 USES OF CIRCADIAN GENE mPER2 |
| 08/26/2004 | WO2004011599A3 Polypeptide cleavage process |
| 08/26/2004 | WO2004004642A3 TCELL TOLERANCE AND MODULATION OF AUTOIMMUNITY BY CD8α-CD4+ DENDRITIC CELLS |
| 08/26/2004 | WO2004003150A3 Modulators and modulation of the interacton between rgm and neogenin |
| 08/26/2004 | WO2004000207A3 Toxin-phage bacteriocide antibiotic and uses thereof |
| 08/26/2004 | WO2003104932A3 Evolutionary algorithm for ion channels |
| 08/26/2004 | WO2003101397A3 Tetravalent dengue vaccines |
| 08/26/2004 | WO2003095475A3 Peptide compounds and their use as protease substrates |
| 08/26/2004 | WO2003093411A3 Ice1, a regulator of cold induced transcriptome and freezing tolerance in plants |
| 08/26/2004 | WO2003092602A3 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants |
| 08/26/2004 | WO2003091447A3 D1-1 nucleic acids, polypeptides and related methods |
| 08/26/2004 | WO2003091399A3 Production and use of salt tolerant and culture density tolerant organisms |
| 08/26/2004 | WO2003087320A3 Antagonists of il-21 and modulation of il-21-mediated t cell responses |
| 08/26/2004 | WO2003077859A3 Method of inducing an enhanced immune response against hiv |
| 08/26/2004 | WO2003055440A3 Compositions and methods for the treatement of immune related diseases |
| 08/26/2004 | WO2003046147A3 Novel human g-protein coupled receptor, hgprbmy31, and variants and methods of use thereof |
| 08/26/2004 | WO2002102320A3 Fce fusion proteins for treatment of allergy and asthma |
| 08/26/2004 | WO2002079447A8 Avian lysozyme promoter |
| 08/26/2004 | WO2002044334A3 Recombinant rsv virus expression systems and vaccines |
| 08/26/2004 | WO2002030268A3 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| 08/26/2004 | US20040168217 used to enhance tissue culture response, induce somatic embryogenesis, induce apomixis, increase transformation efficiency or increase recovery of regenerated plants; genetic engineering |
| 08/26/2004 | US20040168209 Novel murine polynucleotide sequences and mutant cells and mutant animals defined thereby |
| 08/26/2004 | US20040167318 comprising treating the collagen-containing portion with a weak acid solution in order to solubilize and collect the collagen-derived protein fraction; for drugs/cosmetics/foods |
| 08/26/2004 | US20040167317 for treating lymphocyte-related disorders using self-assembling molecular complex designated pre-pro-B cell growth stimulating factor (PPBSF); genetic engineering |
| 08/26/2004 | US20040167189 Materials and methods for inhibiting Wip1 |
| 08/26/2004 | US20040167089 Immunostimulatory nucleic acid molecules |
| 08/26/2004 | US20040167074 Therapeutic applications of mFLINT polypeptides |
| 08/26/2004 | US20040167072 Inhibitors of receptor activator of NF-kappaB and uses thereof |
| 08/26/2004 | US20040167071 treating with a solution of base at a pH of 10-13 to inactivate prions in a manner that does not adversely affect the biological activity; removing prions from a lipoprotein solution by contacting with an adsorbant that binds more tightly to the lipoprotein than to the prion, such as silica |
| 08/26/2004 | US20040167068 Neisseria ORF2086 proteins; immunogenic compositions that elicit bactericidal antibodies to multiple neisserial strains; react with the surface of multiple strains; confer passive protection against a live challenge; and/or prevent colonization. |
| 08/26/2004 | US20040167067 ESM-1 gene differentially expressed in angiogenesis, antagonists thereof, and methods of using the same |
| 08/26/2004 | US20040167066 Cleavage and polyadenylation complex of precursor mrna |
| 08/26/2004 | US20040167061 Substantially homogeneous bio-affecting material having a pre-determined ratio of bioaffecting component to cell targeting component, the method for making such a material and the method of its use |
| 08/26/2004 | US20040167060 Inhibitor and stimulator of stem cell proliferation and uses thereof |
| 08/26/2004 | US20040166566 Novel promoter |
| 08/26/2004 | US20040166565 for treating diseases relating to angiogenesis; fusion protein possesses ribosome inactivating activity and ability to bind to cellular vascular endothelial growth factor (VEGF) receptors |
| 08/26/2004 | US20040166563 used for transformation efficiency, to stimulate plant cell growth, including stem cells, organogenesis, and somatic embryogenesis, and to induce apomixis; genetic engineering |
| 08/26/2004 | US20040166561 Novel intein and uses thereof |
| 08/26/2004 | US20040166546 Cytoplasmic antigens for detection of candida |
| 08/26/2004 | US20040166543 Regulation of cell growth by MUC1 |
| 08/26/2004 | US20040166538 Multimeric protein comprising ligand binding domain for use in identifying modulator associated with ligand/receptor binding activity; detecting posttranslational modification-dependent polypeptide associations; drug screening |
| 08/26/2004 | US20040166530 F-box proteins and genes |
| 08/26/2004 | US20040166528 Novel method for integrating genes at specific sites in mammalian cells via homologous recombination and vectors for accomplishing the same |
| 08/26/2004 | US20040166517 Diagnosing breast cancer via presence of sulphate transporter proteins; antitumor agents |
| 08/26/2004 | US20040166507 Comprises nucleotide sequences coding aspartyl protease for identifying modulators for treatment of nervous system disorders; enzyme inhibitors |
| 08/26/2004 | US20040166501 Transmembrane proteins for identifying agonist for diagnosis, prevention and treatment of cardiovascular, neurological, gastrointestinal, lipid metabolism, cell proliferative and autoimmune/inflammatory disorders |
| 08/26/2004 | US20040166500 Comprises nucleotide sequences coding encoding secretory polypeptides that contain signal peptides and/or transmembrane domains for use in diagnostic assays and toxicity testing |
| 08/26/2004 | US20040166497 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 08/26/2004 | US20040166490 Comprises nucleotide sequences coding cancer associated protein (CA protein) for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 08/26/2004 | US20040166488 Viral genome for use in generating polyclonal and monoclonal antibodies, hepatitis gene therapy models, and antiviral drug screening |
| 08/26/2004 | US20040166486 RNA three dimensional structure (pseudoknot) which stimulates/activates protein synthesis; enhancement of cell-free translation of heterologous polypeptides |
| 08/26/2004 | US20040166150 Mixture of expression vector for antihemophilic factor and lipid |
| 08/26/2004 | US20040166121 Viricides from transgenic plant; dna sequences codes gene expression on surface of antigen ; insertion of nucleotide sequence into plant; genetic engineering |
| 08/26/2004 | US20040166120 Polypeptides; free of adjuvants; antigen immunology response |
| 08/26/2004 | US20040166118 Immunocastration of pigs |
| 08/26/2004 | US20040166117 Overexpression of protease hepsin; induce immunology response; inoculation with hepsin peptide; monitoring immunotherapy |
| 08/26/2004 | US20040166116 Polypeptides containing polymorphisms of the repeated regions of pertactin in Bordetella pertussis, Bordetella parapertussis, and Bordetella bronchiseptica, their use in diagnostics, and in immunogenic compositions |
| 08/26/2004 | US20040166109 Modulator polypeptide for regulation of intracellular endocytosis of amyloid precursor proteins; diagnosis and treatment of neurodegenerative disorders |
| 08/26/2004 | US20040166105 Compositions and methods relating to breast specific genes and proteins |
| 08/26/2004 | US20040166098 Insulin-secreting immortalized liver cell line modified by glucose sensitivity |
| 08/26/2004 | US20040166097 Therapy for bone disease or lung defect |
| 08/26/2004 | US20040166061 drug screening for antidiabetic or antiobesity agents by determining whether a test compound activates expression of the human transcription factor gene FKHL14/FOXC2, winged helix protein; using mouse model of obesity to test the potential drug |
| 08/26/2004 | US20040166026 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 08/26/2004 | US20040164023 Purification process comprising microfiltration at elevated temperatures |
| 08/26/2004 | DE4119288B4 Verfahren zur Schichtenfiltration von pharmazeutischen, biologischen, chemischen oder dergleichen Flüssigkeiten Process for the layers filtration of pharmaceutical, biological, chemical, or the like liquids |
| 08/26/2004 | DE10306789A1 Composition for administration to living organisms, useful for labeling treated organisms, comprises active agent and a protein complex comprising viral capsomers |
| 08/26/2004 | CA2556351A1 Antimicrobial agents from streptococcus mitis and streptococcus oralis |
| 08/26/2004 | CA2555510A1 Antiplasmin cleaving enzyme |
| 08/26/2004 | CA2520591A1 Improved heat shock protein-based vaccines and immunotherapies |
| 08/26/2004 | CA2516344A1 Tra16 a tr4/tr2 repressor |
| 08/26/2004 | CA2515699A1 Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers |
| 08/26/2004 | CA2515208A1 Nell peptide expression systems and bone formation activity of nell peptide |
| 08/26/2004 | CA2515203A1 Immunocompromised rodents as dual color tumor models |
| 08/26/2004 | CA2514969A1 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof |
| 08/26/2004 | CA2514955A1 Compositions for modulating immune cell activity and methods for detection thereof |
| 08/26/2004 | CA2514316A1 Compositions and methods for enhancing apoptosis |
| 08/26/2004 | CA2513061A1 Hsp60 from arthrobacter |
| 08/26/2004 | CA2512644A1 Gene resistant to aphis gossypii |
| 08/26/2004 | CA2456873A1 West nile virus proteins and genes coding the foregoing and their use in vaccinal, therapeutic and diagnostic applications |
| 08/25/2004 | EP1449925A1 Method of diagnosis of type 2 diabetes |
| 08/25/2004 | EP1449922A2 Nucleic acid fragments and polypeptide fragments derived from M. tuberculosis |
| 08/25/2004 | EP1449921A2 Novel biologically active polypeptides, preparation thereof and pharmaceutical composition containing said polypeptides |
| 08/25/2004 | EP1449920A1 Non-human transgenic mammals used as models for human pathologies originating from stem cells |
| 08/25/2004 | EP1449918A1 Process for producing l-amino acid using escherichia |
| 08/25/2004 | EP1449917A1 PROCESS FOR PRODUCING L−AMINO ACID USING ESCHERICHIA |